Mesoblast International Sàrl clinical trials
A subsidiary of Mesoblast Limited
The registry lists 5 studies whose lead sponsor is Mesoblast International Sàrl. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 31, 2025.
Registry sponsor names on this page
- Mesoblast International Sàrl5 studies
Something wrong with this grouping? Tell us on the Mesoblast Limited page.
Studies
Recruiting first, then most recently updated. Showing 5 of 5. All Mesoblast Limited studies →
- Intermediate-size Expanded Access Program (EAP), Mesenchymal Stromal Cells (MSC) for Multisystem Inflammatory Syndrome in Children (MIS-C) Associated With Coronavirus Disease (COVID-19)No longer availableNCT04456439
Sponsor listed in the registry: Mesoblast International Sàrl
- Follow-up Study of Chondrogen® Delivered by Intra-Articular Injection Following MeniscectomyCompletedNCT00702741Phase 1/2
Sponsor listed in the registry: Mesoblast International Sàrl
- A Phase I/II Study of Chondrogen Delivered by Intra-Articular Injection Following MeniscectomyCompletedNCT00225095Phase 1/2
Sponsor listed in the registry: Mesoblast International Sàrl
- Intermediate-size Expanded Access Program (EAP), Mesenchymal Stromal Cells (MSC) for Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19 InfectionNo longer availableNCT04366830
Sponsor listed in the registry: Mesoblast International Sàrl
- OTI-010 for Graft-Versus-Host Disease Prophylaxis in Treating Patients Who Are Undergoing Donor Peripheral Stem Cell Transplantation for Hematologic MalignanciesWithdrawnNCT00081055Phase 2
Sponsor listed in the registry: Mesoblast International Sàrl